Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Titanium Transportation Group Reports Profitable Q2 2023, Highlighted By Continued EBITDA Growth In Trucking Segment

Reported 100 basis point expansion in 2023 YTD EBITDA Margin1 Expanded U.S. based freight-brokerage operations to seven locations, adding a new location in Jacksonville, FloridaAnnounced strategic U.S.-based asset acquisition of Crane Transport, Inc. (“Crane”), positioning the Company to enhance its service offerings with Titanium …

EODHD | 14 August 2023

Diversified Royalty Corp. Announces Q2 2023 Results and Strongest Adjusted Revenue(1) Second Quarter in its History

VANCOUVER, British Columbia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce its financial results for the three months ended June 30, 2023 (“Q2 2023”) and six months ended June 30, 2023. …

EODHD | 14 August 2023

Optiva Inc. Reports Second Quarter 2023 Financial Results

All amounts are stated in United States dollars unless otherwise indicated Revenue of $11.1 millionTotal Contract Value (“TCV”)1 bookings of $20.0 millionGross margin of 65%Adjusted EBITDA1 loss of $0.3 millionAdjusted EPS1 loss of ($0.21)$13.0 million of cash TORONTO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- …

EODHD | 14 August 2023

Declining Stock and Solid Fundamentals: Is The Market Wrong About ALS Limited (ASX:ALQ)?

ALS (ASX:ALQ) has had a rough three months with its share price down 6.8%. However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising. Particularly, we will be paying attention to ALS' …

EODHD | 14 August 2023

Quipt Home Medical Reports Strong Operational Performance With Record Third Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 64% and Adjusted EBITDA Growth of 80%

CINCINNATI, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2023 financial results and operational highlights. These …

EODHD | 14 August 2023

Sagicor Financial (TSE:SFC) shareholders have endured a 21% loss from investing in the stock three years ago

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But if you try your hand at stock picking, your risk returning less than the market. Unfortunately, that's been the case for …

EODHD | 14 August 2023

Petrus Resources Announces Second Quarter 2023 Financial & Operating Results, Revised 2023 Guidance

CALGARY, Alberta, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to report financial and operating results as at and for the three and six months ended June 30, 2023. Q2 2023 HIGHLIGHTS: Production up 44% …

EODHD | 14 August 2023

Titan Medical Announces Appointment of New Independent Member to its Board of Directors

TORONTO, Ontario, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced today the appointment of Dr. Daniel O’Brien, MD, MBA, PhD to its Board of Directors. Dr. O’Brien will also serve on the Audit Committee …

EODHD | 14 August 2023

Sagicor Financial Company Ltd. Reports Second Quarter 2023 Results

This news release for Sagicor Financial Company Ltd. ("Sagicor" or the "Company") should be read in conjunction with the Company's Management's Discussion & Analysis ("MD&A") and the Consolidated Financial Statements for the period ended June 30, 2023. These documents are available on Sagicor's website, …

EODHD | 14 August 2023

HLS Therapeutics Announces Updates to its Credit Agreement

Term is extended, borrowing capacity increases, financial flexibility improves, and interest rates remain relatively unchanged. TORONTO, Aug. 14, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system and cardiovascular markets, announces an extension …

EODHD | 14 August 2023

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions